Letter: mesalazine-a safe drug with rare serious adverse events
Aliment Pharmacol Ther
.
2020 Jun;51(11):1210-1211.
doi: 10.1111/apt.15691.
Authors
Barbara Scrivo
1
,
Sara Renna
1
,
Angelo Casà
1
,
Noemi Monachino
1
,
Fabio S Macaluso
1
,
Ambrogio Orlando
1
Affiliation
1
IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
PMID:
32424923
DOI:
10.1111/apt.15691
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal
Colitis, Ulcerative*
Humans
Mesalamine*
Substances
Anti-Inflammatory Agents, Non-Steroidal
Mesalamine